Stock Market News
Tristel teams up with Parker Labs ahead of US approval for 'Duo'
Infection prevention products manufacturer Tristel has entered into a manufacturing and marketing agreement with US-based Parker Laboratories, whereby Parker will manufacture Tristel's 'Duo' chlorine dioxide foam disinfectant for the north, central and south American market, and would market the product in the ultrasound marketplace throughout the region.
The AIM-traded firm said the collaboration with Parker prepared it for its entry into the United States infection prevention marketplace, in advance of the grant of approval by the United States Environmental Protection Agency for Duo, which was expected during the second half of the current financial year.
It said the initiative was part of its stated intention to enter the North American infection prevention market, unveiled in the company's preliminary results announcement in October 2015.
In pursuit of the plan, on 30 June last year Tristel made a submission for regulatory clearance by the EPA of its Duo chlorine dioxide disinfection foam.
Following EPA federal approval, the company would need to secure state-by-state approval before sales of Duo could commence
The EPA clearance would enable Duo to claim intermediate disinfection of all non-porous surfaces, including those of medical instruments such as ultrasound probes.
Such applications form Tristel's core activity globally, accounting for around 80% of its revenues.
In addition, the board said it was continuing to develop two submissions to be made to the FDA for 510(K) clearance in respect of Duo.
The 510(K) approval would permit Duo to claim high-level disinfection of medical instruments.
"We are very pleased to conclude this collaboration with Parker, whose president and main shareholder we first met some 15 years ago," said Tristel CEO Paul Swinney.
"The company is extremely well-known in ultrasound having been around for so many years under the long-term ownership and management of the Buchalter family.
"Our collaboration will give us the platform to access the ultrasound marketplace throughout the United States and the Americas, first with our EPA approved Duo product and in due course with our FDA approved Duo."
The AIM-traded firm said the collaboration with Parker prepared it for its entry into the United States infection prevention marketplace, in advance of the grant of approval by the United States Environmental Protection Agency for Duo, which was expected during the second half of the current financial year.
It said the initiative was part of its stated intention to enter the North American infection prevention market, unveiled in the company's preliminary results announcement in October 2015.
In pursuit of the plan, on 30 June last year Tristel made a submission for regulatory clearance by the EPA of its Duo chlorine dioxide disinfection foam.
Following EPA federal approval, the company would need to secure state-by-state approval before sales of Duo could commence
The EPA clearance would enable Duo to claim intermediate disinfection of all non-porous surfaces, including those of medical instruments such as ultrasound probes.
Such applications form Tristel's core activity globally, accounting for around 80% of its revenues.
In addition, the board said it was continuing to develop two submissions to be made to the FDA for 510(K) clearance in respect of Duo.
The 510(K) approval would permit Duo to claim high-level disinfection of medical instruments.
"We are very pleased to conclude this collaboration with Parker, whose president and main shareholder we first met some 15 years ago," said Tristel CEO Paul Swinney.
"The company is extremely well-known in ultrasound having been around for so many years under the long-term ownership and management of the Buchalter family.
"Our collaboration will give us the platform to access the ultrasound marketplace throughout the United States and the Americas, first with our EPA approved Duo product and in due course with our FDA approved Duo."
Related share prices |
---|
Tristel (TSTL) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price